|
시장보고서
상품코드
2131156
블로킹 펩티드 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Blocking Peptides Market Size, Share, and Growth Analysis, By Product Type (Custom Blocking Peptides, Catalog Blocking Peptides), By Application (Western Blotting, Immunohistochemistry), By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 블로킹 펩티드 시장 규모는 2024년에 3억 2,000만 달러로 평가되며, 2025년 3억 4,816만 달러에서 2033년까지 6억 8,362만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 8.8%로 성장할 것으로 전망되고 있습니다.
전 세계 블로킹 펩티드 시장은 신약 개발 및 진단에 필수적인 단백질 간 상호작용을 억제하도록 특별히 설계된 합성 올리고펩티드로 구성되어 있습니다. 정밀 의학이 확산됨에 따라 높은 특이성을 바탕으로 세포내 신호 전달 경로를 분석하려는 수요가 급증하고 있습니다. 당초에는 학술 부문에서 활용되었으나, 합성 서비스를 제공하는 계약 연구 기관(CRO)의 진입으로 인해 이 시장은 크게 확대되었습니다. 현재, 바이오의약품에 대한 투자 확대와 스크리닝에 대한 집중으로 인해 연구에서 차단 펩티드의 중요성이 높아지고 있습니다. 이는 특히 종양학 및 면역요법 부문에서 두드러지며, 제약 기업은 표적 검증에 펩티드 차단제를 활용하여 신약 개발의 효율을 높이고 있습니다. AI 기술의 통합으로 펩티드 설계는 더욱 고도화되어, 펩티드와 표적 간의 상호작용을 신속하게 예측하고 연구개발 일정을 최적화할 수 있게 되었습니다.
전 세계 차단 펩티드 시장의 성장 요인
전 세계 차단 펩티드 시장의 주요 성장 동인은 암, 자가면역 질환, 감염증 등 다양한 질환을 치료하기 위한 첨단 치료 솔루션에 대한 수요 증가입니다. 연구자와 제약 기업이 더욱 표적화된 치료법 개발에 주력함에 따라 특정 생물학적 상호작용을 억제하는 분자인 차단 펩티드의 필요성이 두드러지고 있습니다. 약물전달 시스템 및 맞춤형 의료 분야의 혁신 또한 이 시장을 지원하고 있습니다. 차단 펩티드는 부작용을 최소화하면서 효능을 높이는 매우 특이적인 치료 접근법을 가능하게 하기 때문입니다. 또한 진단 및 연구 부문에서 이러한 펩티드의 응용이 확대되면서 시장 성장을 더욱 촉진하고 있습니다.
전 세계 차단 펩티드 시장의 제약 요인
전 세계 블로킹 펩티드 시장에 영향을 미치는 주요 제약 요인 중 하나는 이러한 펩티드의 개발 및 제조 과정에 수반되는 높은 비용입니다. 고품질 차단 펩티드의 제조에는 대개 첨단 기술 및 전문 시설이 필요하며, 이는 최종 소비자 가격 상승으로 이어질 가능성이 있습니다. 또한 의약품 및 생명공학 제품을 규제하는 엄격한 규제 체계로 인해 승인 절차가 복잡해지고 비용이 더욱 상승할 뿐만 아니라, 중소기업의 시장 진입이 제한될 가능성이 있습니다. 이러한 재정적 장벽은 연구 투자를 저해하고, 펩티드 기반 치료법의 혁신을 둔화시키며, 궁극적으로 시장의 전반적인 성장을 방해할 우려가 있습니다.
세계 차단 펩티드 시장의 동향
전 세계 차단 펩티드 시장에서는 정밀한 설계와 첨단 펩티드 공학에 대한 뚜렷한 추세가 나타나고 있습니다. 최첨단 툴의 통합을 통해 연구자들은 특이성이 높은 차단 펩티드 서열을 생성할 수 있게 되어, 오프타겟 효과를 최소화하고 전임상 검증 과정의 효율을 높이고 있습니다. 계산 모델링, 고처리량 스크리닝, 구조생물학을 활용한 협업 생태계는 신약 개발 파이프라인을 혁신하고, 신속한 반복 개발과 임상 후보 화합물로의 보다 확실한 전환을 촉진하고 있습니다. 이러한 움직임은 생명공학 기업과 계약연구기관(CRO) 간의 제휴를 강화하고 있으며, 새로운 표적 질환에 정확하게 대응하고 치료 응용 분야의 혁신을 가속화하는 역동적인 환경을 조성하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 블로킹 펩티드 시장 규모 : 제품 유형별
세계의 블로킹 펩티드 시장 규모 : 용도별
세계의 블로킹 펩티드 시장 규모 : 최종사용자별
세계의 블로킹 펩티드 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.09.23Global Blocking Peptides Market size was valued at USD 320.0 Million in 2024 and is poised to grow from USD 348.16 Million in 2025 to USD 683.62 Million by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).
The global blocking peptides market consists of synthetic oligopeptides specifically engineered to inhibit protein-protein interactions, essential for drug discovery and diagnostics. As precision medicine gains momentum, the demand for dissecting cellular pathways with high specificity has surged. Initially utilized in academic settings, this market has expanded significantly through the involvement of contract research organizations offering synthesis services. Today, increased investments in biologics and a focus on screening are driving the importance of blocking peptides in research. This is particularly evident in oncology and immunotherapy, where pharmaceutical companies leverage peptide blockers for target validation, improving the efficiency of drug development. The integration of AI technologies is further enhancing peptide design, enabling rapid predictions of peptide-target interactions and optimizing research and development timelines.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blocking Peptides market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blocking Peptides Market Segments Analysis
Global blocking peptides market is segmented by product type, application, end user and region. Based on product type, the market is segmented into Custom Blocking Peptides and Catalog Blocking Peptides. Based on application, the market is segmented into Western Blotting, Immunohistochemistry, ELISA and Others. Based on end user, the market is segmented into Academic Institutes, Biotechnology Companies, Pharmaceutical Companies and CROs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Blocking Peptides Market
A key market driver for the global blocking peptides market is the increasing demand for advanced therapeutic solutions aimed at addressing various diseases, including cancer, autoimmune disorders, and infectious diseases. As researchers and pharmaceutical companies focus on developing more targeted therapies, the necessity for blocking peptides-molecules that inhibit specific biological interactions-has gained prominence. Innovations in drug delivery systems and personalized medicine are also propelling the market, as blocking peptides allow for highly specific treatment approaches that enhance efficacy while minimizing side effects. Additionally, the expanding application of these peptides in diagnostics and research further fuels market growth.
Restraints in the Global Blocking Peptides Market
One significant restraint affecting the global blocking peptides market is the high cost associated with the development and manufacturing processes of these peptides. Producing high-quality blocking peptides often requires advanced technologies and specialized facilities, which can lead to increased prices for end consumers. Additionally, the stringent regulatory frameworks governing pharmaceutical and biotechnological products can complicate approval processes, further driving costs up and limiting market entry for smaller players. This financial barrier may deter research investments and slow down innovation in peptide-based therapies, ultimately hindering the overall growth of the market.
Market Trends of the Global Blocking Peptides Market
The Global Blocking Peptides market is experiencing a significant trend towards precision design and advanced peptide engineering. The integration of cutting-edge tools is allowing researchers to create highly specific blocking peptide sequences, minimizing off-target effects and enhancing the efficiency of preclinical validation processes. Collaborative ecosystems that leverage computational modeling, high-throughput screening, and structural biology are transforming discovery pipelines, facilitating rapid iterations and more dependable translation into clinical candidates. This movement is prompting stronger alliances between biotechnology firms and contract research organizations, cultivating a dynamic environment that adeptly addresses new disease targets and accelerates innovation in therapeutic applications.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Blocking Peptides Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Custom Blocking Peptides
- Catalog Blocking Peptides
Global Blocking Peptides Market Size by Application & CAGR (2026-2033)
- Market Overview
- Western Blotting
- Immunohistochemistry
- ELISA
- Others
Global Blocking Peptides Market Size by End User & CAGR (2026-2033)
- Market Overview
- Academic Institutes
- Biotechnology Companies
- Pharmaceutical Companies
- CROs
Global Blocking Peptides Market Size & CAGR (2026-2033)
- North America (Product Type, Application, End User)
- US
- Canada
- Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Proteintech Group, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Santa Cruz Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneTex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novus Biologicals LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abnova Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boster Biological Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rockland Immunochemicals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LSBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sino Biological, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Invitrogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PeproTech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
